Crosslinking for Microbial Keratitis To Treat or not to Treat?

Slides:



Advertisements
Similar presentations
Corneal collagen cross-linking: 2014 and beyond
Advertisements

Paradox of Corneal CXL and Infectious Keratitis: To Do or Not to Do? None of the authors have any financial disclosure to make Vishal Vohra,MS (Presenting.
Amit Gupta, MS Swapnil M. Parchand, MBBS Jagat Ram, MS Arunaloke Chakrabarti, MD Amod Gupta, MS Advanced Eye Centre, Post Graduate Institute of Medical.
Ömür Uçakhan-Gündüz, MD Betül N. Bayraktutar, MD
Untraviolet Riboflavin Collagen Crosslinking in Keratoconus – Initial Results J Brady, W Power, W Lee The Authors have no financial interetsts in the subject.
Venting Incisions in DSAEK Patients: Is It an Absolute Necessity?
Northern Colorado Eye Center Continuing Education Event Corneal Collagen Cross-linking September 20, 2014 S. Lance Forstot, MD, FACS Corneal Consultants.
Instructional course IC 1 Corneal cross linking therapy: Operative technique Auhor: Kristina Mikek, Slovenia Co. Authors : Carina Koppen, Belgium Zoltan.
MICROBIAL KERATITIS FOLLOWING EPI-OFF CORNEAL COLLAGEN CROSSLINKING PROCEDURE Dr. K V Satyamurthy Dr. Jaysheel V N Cornea-Refractive Surgery Dept MM Joshi.
Corneal melting after collagen cross-linking for keratoconus Journal of Medical Case Reports,2011 By Ibrahim almahuby Dr.Georgios Labiris.
Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: Corticosteroids to Treat Bacterial Keratitis Ray KJ, Srinivasan M, Mascarenhas.
Long term Follow-up of PK cases with herpetic Leukomas, treated with topical Acyclovir and steroids WORLD CORNEA CONGRESS VII 2015 Ramon Naranjo-Tackman,MD.
Swept Source Optical Coherence Tomography for Evaluation of Posterior Corneal Changes after Refractive Surgery Dr. Tommy Chung Yan Chan Dr. Vishal Jhanji.
Are topical NSAIDs a safe and effective treatment for Corneal Abrasions? Department of Emergency Medicine University of Pennsylvania Health System Andrew.
Evaluation of Bactericidal and Fungicidal Activity of Riboflavin Plus UVA Irradiation for Corneal CXL Authors Ashok Sharma, Cornea Centre, Chandigarh,
Effects of Smoking on Corneal Thickness Candice Giordano, MD February 25, 2011.
UVA/riboflavin for infectious keratitis. Prospective randomized double blind trial. Early experience. Erik Letko, MD 1 ; Francis W. Price, MD 1 ; Carlindo.
Prof. A. John Kanellopoulos, MD 1 Long-term Safety and Efficacy of High-Fluence Collagen Crosslinking of the Vehicle Cornea in.
Collagen cross-linking (CXL) for keratoconus (KC) with simultaneous topographical-guided photorefractive keratectomy (TG-PRK) Simon Holland, MD, FRCSC,
Pachymetric changes during corneal collagen cross-linking and effect of hydroxipropylmethylcellulose on corneal thickness Faik Oruçoğlu (Orucov) Kudret.
Corneal CXL in Children With Progessive Keratoconus Author do not have any financial interest in the surgical procedure or the medicines used in this study.
Primary HIV-1 Infection Pathogenesis, Diagnosis, and Treatment Summary of Evidence Martin Markowitz M.D. Clinical Director and Staff Investigator Aaron.
Indications for and Outcomes of Therapeutic Penetrating Keratoplasty Sonika Gupta Consultant Ophthalmology Max Eye Care New Delhi, India Author has no.
The Role of Benzalkonium Chloride in the Occurrence of Punctate Keratitis: A Meta- Analysis of Randomized, Controlled Clinical Trials S Trocme, MD, 1 L-J.
Khairidzan Mohd Kamal MD
“Corneal CXL for the Treatment of Non- Responding Infectious Keratitis ” Cristian A. Cartes, MD ; Miguel Srur, MD; Leonidas Traipe, MD Fundación Oftalmológica.
Results of Collagen Crosslinking followed by posterior chamber toric implantable collamer lens implantation in patients with Keratoconus & High Myopia.
The authors have no financial interest in this work Riboflavin/ UVA Combination For Acanthamoeba Isolates. Evaluation of in Vitro Cysticidal Antiamoebic.
Management of Mycotic Keratitis
Choice of Treatment Protocol for Cross-linking
Corneal collagen cross-linking: 2015 and beyond Dr Elsie Chan Consultant Ophthalmologist, Royal Victorian Eye and Ear Hospital Honorary Fellow, CERA, University.
Epithelial Dendritic Cells and Subbasal Nerve Plexus in Infectious Keratitis: An In Vivo Confocal Microscopy Study. Andrea Cruzat, MD, Dimos Mantopoulos,
Deep Anterior Lamellar Keratoplasty (DALK) Vs Penetrating Keratoplasty (PK) in patients with Keratoconus (KC). Dr. K.S.SIDDHARTHAN Aravind Eye Hospital.
Ramon C. Ghanem, M.D. 1, 2 ; Vinícius C. Ghanem, M.D. 1, 2 ; Marcony Santhiago, M.D. 2,3 ; Marcelo V. Netto, M.D. 2,3 ; Steven E. Wilson, M.D Sadalla.
A Case of Beauveria Bassiana Keratitis Confirmed by Gene Sequencing Sung-Dong Chang, M.D., Jong-Hwa Jun, M.D. Department of Ophthalmology, School of Medicine,
Poster produced by Faculty & Curriculum Support (FACS), Georgetown University School of Medicine LASIK Combined with Corneal Cross-linking in Eyes with.
Collagen Cross-Linking with Photoactivated Riboflavin (PACK-CXL) for the Treatment of Advanced Infectious Keratitis with Corneal Melting Ophthalmology.
In Vivo Confocal Microscopy after Corneal Collagen Crosslinking
Volume 121, Issue 7, Pages (July 2014)
The Authors have no financial interest
Low intensity versus high intensity CXL
CORNEAL EPITHELIAL IMAGING
Osmotic Riboflavin and transepithelial CXL
Prophylactic collagen cross-linking (pCXL) in high risk (HR) LASIK
Influence of UVA-Riboflavin corneal collagen cross-linking on biomechanical properties of keratoconic eyes David Zadok MD, Yakov Goldich MD, Yaniv Barkana.
Bevacizumab and corneal patology
Toric Topographically Customized Transepithelial, Pulsed, Very High-Fluence, Higher Energy and Higher Riboflavin Concentration Collagen Cross-Linking in.
Dr. Sandeep Arora FRCS Dr Ashish Nagpal FRCS
Collagen Cross-Linking in Early Keratoconus: Before and After
Accelerated CXL is not proven yet
Crosslinking with Simultaneous Implantation of Intrastromal Corneal Ring Segments in Keratoconus: Safe and Efficacy Author: Luiz Antonio de Brito Martins.
CORNEAL PERFORATION AFTER CROSSLINKING TREATMENT FOR KERATOCONUS
From: Corneal Cross-Linking with Riboflavin and UV-A in the Mouse Cornea in Vivo: Morphological, Biochemical, and Physiological Analysis Trans. Vis. Sci.
Chapter 7 The Hierarchy of Evidence
Management of Keratoconus using KeraSoft IC
Collagen cross-linking (CXL) for keratoconus (KC) with simultaneous topographical-guided photorefractive keratectomy (TG-PRK) Simon Holland, MD, FRCSC,
JAMA Ophthalmology Journal Club Slides: Effect of Oral Voriconazole on Fungal Keratitis Prajna NV, TKrishnan T, Rajaraman R, et al; Mycotic Ulcer Treatment.
ECEN 2010 April 28,2014 Frank Barnes.
化工学院第七届国际交流月系列讲座 邀请人:王文俊 化学工程与生物工程学院 化学工程联合国家重点实验室(浙江大学)
Effects of corneal collagen crosslinking on Ocular Response Analyzer waveform-derived variables in keratoconus and post-LASIK ectasia Spatial treatment.
H Nayak, A Patel, S Gudsoorkar, V Kumar University Hospital Wales
Corneal Effects of 1.5% Levofloxacin Ophthalmic Solution (IQUIX®) in Humans Mark B. Abelson, MD1,2 Gail Torkildsen, MD2; Aron Shapiro2; Ingrid Lapsa2.
Associate Professor of Ophthalmology
Pachymetry Fluctuations During Corneal Crosslinking (CXL)
Principles of Antimicrobial Therapy
Spatially Selective Two-Photon Induction of Oxidative Damage
Shorter Duration, Higher Ultraviolet A Irradiation (UVA) Fluence Collagen Cross-linking (CCL) for Keratoconus (KCN) Frank A. Killian, MD and A. John Kanellopoulos,
Principles of Antimicrobial Therapy
The Effect of Corneal Thickness on Ocular Drug Penetration
10 min Charleen T. Chu, MD, PhD
Presentation transcript:

Crosslinking for Microbial Keratitis To Treat or not to Treat? Dr. Kendrick Shih MBBS, MRes (Medicine) MRCSEd, FCOphthHK, FHKAM Department of Ophthalmology Li Ka Shing Faculty of Medicine

Acknowledgements Professor Vishal Jhanji, UMPC Eye Centre, USA Dr. Tommy Chan, DOVS The Chinese University of Hong kong, Hong Kong SAR

Declaration I do not have any financial interests in the drugs or products discussed in this presentation

Introduction The current mainstay of microbial keratitis treatment is the use of local antibiotics However the treatment takes time to for effect (time is cornea) and is associated with potentially serious ocular surface toxicity and microbial resistance Cornea cross-linking (CXL) is an established treatment for preventing progressive keratoconus or ectasia Increases biomechanical strength of the anterior cornea stroma Since 2000, the use of CXL has been extended to the treatment of microbial keratitis as form of adjunctive treatment – Photoactivated Chromophores for Cross-linking (PACK-CXL) Randleman JB et al. Surv Ophthalmol. 2015 Schnitzler E et al. Klin Monbl Augmenheikd. 2000 Iseli HP et al. Cornea. 2008

Mechanism of action: Not Fully Known Photo-activation of a chromophore can release reactive oxygen species and theoretically reduce microbial load, similar to a disinfectant. Oxidation of pathogen DNA and RNA ROS damage of pathogen cell walls Increased corneal stiffness and resistance to enzymatic digestion Killing of inflammatory and immune cells (apoptosis) Kumar V et al. Photochem Photobiol. 2004 Martins SA et al. IOVS. 2008 Spoerl E et al. Curr Eye Res. 2004 Wollensak G et al. Cornea. 2004

PACK-CXL Protocol Standard Dresden protocol most commonly used Epithelium-off Application of isotonic riboflavin for 30 minutes (5 minute intervals) 365-nm UVA light exposure (3mW/cm2) for 30 minutes Anterior segment optical coherence tomography (AS-OCT) is a useful diagnostic tool for assessing infiltrate depth before treatment and monitoring afterward A minimal corneal thickness of 400 µm is required to prevent any endothelial damage from CXL

Important Considerations Intraoperative pachymetry and hypotonic riboflavin may help ensure sufficient endothelial protection during CXL in borderline thin corneas. Use of riboflavin/UV-A should be avoided in patients with a history or suspicion of herpes simplex. Herpes is activated by ultraviolet irradiation Fluorescein stain should be avoided before use of photo-activated riboflavin, because it competes for absorption of UV-A light and reduces antimicrobial efficacy The total number of reported acanthamoeba cases treated with PACK-CXL is too few to accurately assess success rate and confidence interval. Given the mixed results with cysts and trophozoites in laboratory studies and that the infectious organisms are often deep in the cornea after prolonged infection,

Proposed Variations to Standard Dresden Protocol Important to note that Dresden protocol was not designed to target microbial keratitis: Avoid enlarging epithelial defect to avoid delayed healing vs Remove epithelium beyond area of observed infiltrate to improve riboflavin penetration Alter riboflavin concentration to improve killing effect Higher concentration (0.25 vs 0.1%) for ↑ fungicidal effect Lower concentrations (0.03 vs 0.09% with longer UVA exposure) for ↑ bactericidal effect Prolonging riboflavin instillation time ↑ collagen compaction, ↑ resistance to enzymatic digestion May use accelerated protocol (16 mW/cm2 for 5 min, 36 mW/cm2 for 2.5 min) – controversial

Major Questions How safe and effective is PACK-CXL? Adjuvant therapy vs monotherapy? What type of microbial keratitis can be treated with PACK-CXL? When is the optimum time point for treating microbial keratitis with PACK-CXL? The total number of reported acanthamoeba cases treated with PACK-CXL is too few to accurately assess success rate and confidence interval. Given the mixed results with cysts and trophozoites in laboratory studies and that the infectious organisms are often deep in the cornea after prolonged infection,

What Does the Evidence Say Approximately 30 published studies to date: 2 systematic reviews and 1 meta-analysis 2 randomized controlled trials 15 case series 10 case reports Treatment for bacteria, fungal species, acanthamoeba cysts , trophozoites Most employed standard Dresden protocol Major limitations include lack of masking, a heterogenous group of conditions with different microbial agents and differences in patient demographics Price MO et al. Curr Opin Ophthalmol. 2016 Chan TC et al. Curr Opin Ophthalmol. 2016

How Safe and Effective is PACK-CXL? Overall 87% success rate with PACK-CXL for microbial keratitis (defined as complete re-epithelialization and infiltrate resolution) Similar to topical antibiotic therapy (5-year historical comparison and control groups in RCTs), although in one RCT PACK-CXL group had patients with larger ulcers HOWEVER, may significantly shorten re-epithelialization in early cases (17 vs 24 days) No difference in re-epithelialization rate and final VA in advanced cases, but treated group had no recurrences or perforations Papaioannou et al. Cornea. 2016 Said et al. Ophthalmology. 2014 Bamdad et al. Cornea. 2015 Price et al. J Refract Surg. 2012 Vajpayee et al. Clin Experiment Ophthalmol. 2015

How Safe and Effective is PACK-CXL? Additional observations: May have role in antibiotic-resistant cases Smaller ulcers associated with higher success rates in bacterial and fungal keratitis Presence of hypopion associated with lower success rate

Adjuvant Therapy vs Monotherapy? Vast majority of studies used PACK-CXL as adjuvant therapy Only 3 studies had patients with use of PACK-CXL as monotherapy Makadoumi et al had 16 patients with bacterial keratitis (unknown if consecutive or not) who all had re-epithelialization and resolution of infiltrate with PACK-CXL alone Tabibian et al had one case of fungal keratitis treated with accelerated PACK-CXL (9 mW/cm2 for 10 min) that healed within 3 days Fisher et al had one case of fungal keratitis treated with standard PACK-CXL that healed within 3 days as well Makdoumi et al. Graefes Arch Clin Exp Ophthalmol. 2012 Tabibian et al. J Refract Surg. 2014 Price et al. J Refract Surg. 2012

Which Microbes are Most Susceptible? Mixed results for heterogenous groups of microbial keratitis from largest RCT Faster recovery in bacterial keratitis with infiltrate size less than 2.5 mm Poor response to CXL in fungal keratitis Inadequate case number to accurately assess success rate for acanthamoeba keratitis Price et al. J Refract Surg. 2012

Optimum Treatment Time Point? A better treatment response with superficial corneal infiltrate involving the anterior third of the stroma However debatable whether depth of infection should be monitored via ASOCT (infiltrate depth) vs confocal microscopy (microbial depth), especially for deeply penetrating conditions like fungal keratitis Deeper microbial penetration associated with disease flares after PACK-CXL Alsherhri et al demonstrated in ex vivo human corneas that PACK-CXL effectively reduced microbial load up to treatment penetration depth on confocal microscopy Shetty et al. Br J Ophthalmol. 2014 Price et al. J Refract Surg. 2012 Alshehri et al. IOVS. 2016

Summary Cornea collagen cross-linking is a potentially useful adjunctive treatment for the management of selective cases of bacterial keratitis Existing evidence does not support its routine use in fungal or amoebic keratitis Treatment effectiveness is limited by depth of cross-linking (250-300 μm). Therefore it may be potentially more useful in early keratitis Richoz et al have recently shown that an accelerated protocol using 18 mW/cm2 for 5 minutes and even 36 mW/cm2 for 2.5 minutes allows to maintain the same high bacterial killing rate observed in earlier studies using the Dresden protocol

Future Prospect Larger randomized, controlled studies are needed to accurately assess the safety and efficacy of optimized PACK-CXL protocols relative to standard antimicrobial treatments Improving the treatment by modifying parameters such as time, duration of irradiance and type of chromophore Richoz et al have recently shown that an accelerated protocol using 18 mW/cm2 for 5 minutes and even 36 mW/cm2 for 2.5 minutes allows to maintain the same high bacterial killing rate observed in earlier studies using the Dresden protocol

Thank You Email: kcshih@hku.hk